The American administration’s adviser on the vaccine program, Dr. Moncef Slaoui stated that Americans could receive the first vaccine on December 11 at the earliest.
Slaoui said that with the approval of the vaccine, the vaccine will move and deploy to the places notified by the states within 24 hours.
Slaoui made this statement to NBC television.
The Drug and Food Administration’s FDA’s consultants will consider approving the emergency use of the vaccine jointly developed by Pfizer and BioNTech on December 10.
It is foreseen that the vaccine in question will be given in two doses, 3 weeks apart. The effectiveness of the vaccine was announced as 95 percent. Pfizer plans to produce enough vaccines for 25 people by the end of the year.
Slaoui said the vaccine will be distributed according to the population of each state. Each person will decide who will get the first vaccine.
It is stated that the priority group of the vaccine will be healthcare workers and the elderly who may die due to the virus.
According to Slaoui, 70 percent of the population must be immunized to achieve community immunity, and this can be achieved in May.
America has to both deliver 330 million vaccines and fight conspiracy theories about the vaccine on social media.
Ron Klain, who will become the General Secretary of the White House on January 20, drew attention to the importance of the transition process in order to avoid delays in the delivery of the vaccine.
Klain emphasized that the information Trump’s Corona team will give to Biden’s team is of vital importance.
Slaoui, on the other hand, told ABC that he did not meet with anyone from the Biden team.
Slaoui also said in a statement to CNN that it is important to provide information to the Biden team.
The number of cases in America has exceeded 12 million.
The number of people who lost their lives is approaching 260 thousand.
The head of the Center for Infectious Diseases at the National Institute of Health, Dr. “We are going through a very difficult increase in America, even globally,” Anthony Fauci said in a statement to NBC.
The effectiveness of the vaccine of the Moderna company, which conducted another vaccine study, was announced as approximately 95 percent. Moderna is also expected to apply to the FDA for vaccine approval soon.